HB Fuller Company formulates, manufactures and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives and other specialty chemicals worldwide. The company is headquartered in Saint Paul, Minnesota.
231 articles
H.B. Fuller shares dropped to a new 52-week low of $48.60 despite reporting better-than-expected quarterly earnings. The decline coincided with significant insider selling by VP Nathan Weaver, contras
H.B. Fuller shares fell to a 52-week low of $48.60 despite 33 years of dividend increases. The company recently rejected a $1.2 billion acquisition bid for its Building Adhesive Solutions business.
H.B. Fuller awarded Bin Dasmal General Trading Co. and Huhtamaki its 2026 Customer Innovation Award for sustainable packaging solutions, while shares rose 46 cents to close at $51.31.
H.B. Fuller is set to report Q3 2026 earnings on September 23rd, with analysts forecasting $1.47 EPS and $948.2 million revenue. The stock maintains a Buy consensus with a price target of $67.86 follo
H.B. Fuller Company will release its Q3 2026 financial results after market close on September 23, 2026. An investor conference call and webcast will follow on September 24 to discuss the findings.
H.B. Fuller received a consensus 'Buy' rating from analysts after reporting quarterly earnings of $1.41 EPS against estimates, with revenue growing 5.8% year-over-year.
H.B. Fuller is expanding Gel-Tac™ microsphere adhesive production at its Italian Pianezze facility to enhance supply responsiveness and reduce carbon footprints. Additionally, the company is developin
H.B. Fuller rejected Ancora Holdings Group's $1.2 billion offer for its Building Adhesives Solutions business, citing undervaluation and operational dis-synergies. The company plans to demonstrate the
Bank of New York Mellon acquired 508,002 shares of specialty chemicals firm H.B. Fuller for approximately $29.6 million. The acquisition boosts institutional ownership to 95.93% amid strong earnings a
H.B. Fuller Company (FUL) analysis highlights a 34.4:1 risk-reward setup targeting a 10.1% gain, outlining institutional trading strategies for various risk profiles.
Zacks Research upgraded H.B. Fuller to a "strong-buy" rating following quarterly earnings beats, despite ongoing board disputes with activist investor Ancora over a $1.2 billion proposal.
Ancora Holdings Group reiterated its offer to acquire H.B. Fuller’s Building Adhesive Solutions segment, criticizing the board's rejection and calling for strategic review to unlock shareholder value.
H.B. Fuller's board unanimously rejected an unsolicited acquisition proposal from Ancora Holdings Group targeting its Building Adhesives Solutions business. The company reported full-year net sales of
H.B. Fuller rejected a $1.1–1.2 billion offer from activist investor Ancora Group Holdings for its building adhesive solutions unit, citing undervaluation. Ancora reaffirmed its intent to acquire desp
H.B. Fuller's board unanimously rejected an unsolicited acquisition proposal from Ancora for its Building Adhesives Solutions business, citing undervaluation. The company will continue its strategic a
H.B. Fuller rejected Ancora Holdings' $1.2 billion unsolicited offer for its Building Adhesive Solutions business, citing undervaluation. The board remains firm despite Ancora's criticism and potentia
H.B. Fuller's board has reportedly rejected Ancora's $1.2 billion bid for its building adhesives solutions segment. The decision follows earlier reports that Engine Capital had urged the company to en
H.B. Fuller rejected Ancora's $1.2 billion offer for its building adhesives unit, citing undervaluation. The activist investor argued the sale would reduce debt and address governance concerns regardi
H.B. Fuller rejected Ancora Holdings' $1.2 billion bid for its building adhesives unit, citing undervaluation. Shares remained flat as the board deemed the proposal lacked key growth information.
Analysts project H.B. Fuller is 19% undervalued with a $73.29 price target based on 2029 revenue forecasts, though risks include weak demand and raw material cost pressures.
H.B. Fuller announced the closure of its Paducah facility by early 2027, leading to over 100 job losses. Union representatives expressed deep disappointment, citing the decision as a blow to dedicated
H.B. Fuller director Teresa J. Rasmussen Trangsrud purchased 1,000 shares worth $65,830. The company is also considering a $1.2 billion acquisition proposal.
H.B. Fuller director Teresa J. Rasmussen Trangsrud bought 1,000 shares at $65.83/share on April 17, 2026, raising her holdings to 3,391 shares per amended Form 4 filing.
Ancora Holding Group proposed acquiring H.B. Fuller’s Building Adhesives Solutions segment for $1.1 to $1.2 billion. H.B. Fuller confirmed the proposal will be evaluated by its Board of Directors.
Bank of America increased its stake in specialty chemicals firm H.B. Fuller by 36.3% to approximately $31.7 million. The company exceeded quarterly earnings expectations with $1.41 EPS and $950.27 mil
S&CO Inc. acquired a $14.1 million stake in H.B. Fuller Company, which recently exceeded quarterly earnings expectations with $1.41 EPS and $950.27 million in revenue.
H.B. Fuller Executive Vice President Nathan Weaver sold approximately $593,000 worth of company stock following option exercises. The transaction occurs amid dividend increases and potential acquisiti
H.B. Fuller shares appear undervalued by 37.1% per DCF models, though P/E ratios remain fair amidst activist pressure and potential acquisitions.
Advanced Medical Solutions Group shareholders approved the sale to H.B. Fuller for £715 million. The acquisition expands H.B. Fuller's medical unit with tissue-healing technologies and targets $55 mil
Activist investor Engine Capital is urging H.B. Fuller's board to conduct a market check for its Building Adhesive Solutions segment and the entire company. This move signals a push to explore strateg
ChemBrief